Epoetin alfa--focus on the geriatric patient. Case study of the anemic patient.
According to the Health Care Financing Administration, the largest group receiving dialysis therapy in the United States, constituting 41%, is persons age 65 and older. With 25% of the population expected to be in this age group by the middle of the next century, increasing attention must be paid to this developing "majority patient population." This article addresses the special requirements, major challenges, and management strategies needed to treat older patients with end-stage renal disease.